New England Journal of Medicine最新文献

筛选
英文 中文
Spinal Tuberculosis. 脊柱结核。
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-17 DOI: 10.1056/NEJMicm2607513
Sara Pereira Henriques, Margarida Mota
{"title":"Spinal Tuberculosis.","authors":"Sara Pereira Henriques, Margarida Mota","doi":"10.1056/NEJMicm2607513","DOIUrl":"https://doi.org/10.1056/NEJMicm2607513","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":84.5,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149221141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Engagement Requirements in Medicaid — Law as a Determinant of Health 医疗补助中的社区参与要求——作为健康决定因素的法律
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-17 DOI: 10.1056/nejmp2608810
Nicole Huberfeld,Paul R. Shafer
{"title":"Community Engagement Requirements in Medicaid — Law as a Determinant of Health","authors":"Nicole Huberfeld,Paul R. Shafer","doi":"10.1056/nejmp2608810","DOIUrl":"https://doi.org/10.1056/nejmp2608810","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"27 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149208675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why Shared-Savings ACOs Have Failed to Deliver for Primary Care 为什么共享储蓄ACOs未能为初级保健提供服务
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-17 DOI: 10.1056/nejmp2605590
Lisa S. Rotenstein,Nicholas Stine,Bruce Landon
{"title":"Why Shared-Savings ACOs Have Failed to Deliver for Primary Care","authors":"Lisa S. Rotenstein,Nicholas Stine,Bruce Landon","doi":"10.1056/nejmp2605590","DOIUrl":"https://doi.org/10.1056/nejmp2605590","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"168 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149208676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What I See before Anyone Speaks 没人说话之前我看到的
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-17 DOI: 10.1056/nejmp2604584
Robert B. Shpiner
{"title":"What I See before Anyone Speaks","authors":"Robert B. Shpiner","doi":"10.1056/nejmp2604584","DOIUrl":"https://doi.org/10.1056/nejmp2604584","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"10 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149208677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integration-Associated Paraspinal Neoplasm after AAV Gene Therapy. AAV基因治疗后整合相关的棘旁肿瘤。
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-15 DOI: 10.1056/NEJMc2607927
Josh N Vo, Yi-Mi Wu, Amer Heider, Xuhong Cao, Rui Wang, Tiffany Pham, Guo Ci Teo, Suresh N Magge, Hemant Parmar, Rajen Mody, Dan R Robinson, Arul M Chinnaiyan
{"title":"Integration-Associated Paraspinal Neoplasm after AAV Gene Therapy.","authors":"Josh N Vo, Yi-Mi Wu, Amer Heider, Xuhong Cao, Rui Wang, Tiffany Pham, Guo Ci Teo, Suresh N Magge, Hemant Parmar, Rajen Mody, Dan R Robinson, Arul M Chinnaiyan","doi":"10.1056/NEJMc2607927","DOIUrl":"10.1056/NEJMc2607927","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"395 15","pages":"1555-1558"},"PeriodicalIF":84.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13671263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema. Lonvoguran Ziclumeran -遗传性血管性水肿的体内CRISPR基因编辑
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-15 Epub Date: 2026-06-13 DOI: 10.1056/NEJMoa2600931
Danny M Cohn, Padmalal Gurugama, Hilary J Longhurst, Emel Aygören-Pürsün, Timothy J Craig, Henriette Farkas, Joshua Jacobs, William R Lumry, Markus Magerl, Jonny Peter, Marc A Riedl, David Maag, Adele Golden, Mrinal Y Shah, Andrea Sutherland, Catherine R Miller, Ahmed M Abdelhady, Yuanxin Xu, James S Butler, David Lebwohl, John Leonard, Aleena Banerji
{"title":"Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.","authors":"Danny M Cohn, Padmalal Gurugama, Hilary J Longhurst, Emel Aygören-Pürsün, Timothy J Craig, Henriette Farkas, Joshua Jacobs, William R Lumry, Markus Magerl, Jonny Peter, Marc A Riedl, David Maag, Adele Golden, Mrinal Y Shah, Andrea Sutherland, Catherine R Miller, Ahmed M Abdelhady, Yuanxin Xu, James S Butler, David Lebwohl, John Leonard, Aleena Banerji","doi":"10.1056/NEJMoa2600931","DOIUrl":"10.1056/NEJMoa2600931","url":null,"abstract":"<p><strong>Background: </strong>Hereditary angioedema is a rare and potentially life-threatening genetic condition characterized by recurrent and debilitating swelling attacks. Lonvoguran ziclumeran (lonvo-z) - an investigational, in vivo gene-editing treatment based on clustered regularly interspaced short palindromic repeats (CRISPR) - is being developed as a single-dose treatment for hereditary angioedema.</p><p><strong>Methods: </strong>In a phase 3, double-blind trial, we randomly assigned, in a 2:1 ratio, patients who were 16 years of age or older and had hereditary angioedema with C1 inhibitor deficiency to receive a single intravenous infusion of lonvo-z (at a dose of 50 mg) or placebo. The primary end point was the number of investigator-confirmed hereditary angioedema attacks per month (the monthly attack rate) from week 5 through week 28 after infusion.</p><p><strong>Results: </strong>A total of 80 patients underwent randomization; 52 were assigned to receive lonvo-z and 28 to receive placebo. As of February 10, 2026, the median duration of follow-up was 7.5 months (range, 4.9 to 12.8). The least-squares mean monthly attack rate from weeks 5 through 28 was 0.26 (95% confidence interval [CI], 0.15 to 0.45) in the lonvo-z group and 2.10 (95% CI, 1.55 to 2.86) in the placebo group (relative difference, -87%; 95% CI, -93 to -78; P<0.001). Adverse events that occurred during or after infusion of lonvo-z or placebo were reported in 92% and 86% of the patients in the lonvo-z and placebo groups, respectively, from day 1 through week 28. Among the adverse events that occurred during or after infusion and more often in the lonvo-z group than in the placebo group, the most common (occurring in >10% of the patients in the lonvo-z group) included infusion-related reaction, headache, fatigue, back pain, and upper respiratory tract infection. No serious or grade 3 or higher adverse events were reported in the lonvo-z group.</p><p><strong>Conclusions: </strong>Among patients with hereditary angioedema, a single intravenous infusion of lonvo-z resulted in a significantly lower rate of hereditary angioedema attacks than placebo. (Funded by Intellia Therapeutics; HAELO ClinicalTrials.gov number, NCT06634420.).</p>","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"1471-1482"},"PeriodicalIF":84.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148254498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended DAPT for Multivessel Coronary Artery Disease. 扩展DAPT治疗多支冠状动脉疾病。
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-15 DOI: 10.1056/NEJMc2610855
Domenico S Castiello, Ernest Spitzer
{"title":"Extended DAPT for Multivessel Coronary Artery Disease.","authors":"Domenico S Castiello, Ernest Spitzer","doi":"10.1056/NEJMc2610855","DOIUrl":"https://doi.org/10.1056/NEJMc2610855","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"395 15","pages":"1559"},"PeriodicalIF":84.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Setmelanotide治疗获得性下丘脑肥胖。
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-15 DOI: 10.1056/NEJMc2610994
Jiafeng Zhang, Xinhui Zhan, Tuo Li
{"title":"Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.","authors":"Jiafeng Zhang, Xinhui Zhan, Tuo Li","doi":"10.1056/NEJMc2610994","DOIUrl":"https://doi.org/10.1056/NEJMc2610994","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"395 15","pages":"1562-1563"},"PeriodicalIF":84.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adapting to Genomic Medicine. 适应基因组医学。
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-15 DOI: 10.1056/NEJMe2608188
Peter Marks
{"title":"Adapting to Genomic Medicine.","authors":"Peter Marks","doi":"10.1056/NEJMe2608188","DOIUrl":"https://doi.org/10.1056/NEJMe2608188","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"395 15","pages":"1541-1542"},"PeriodicalIF":84.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obinutuzumab in Active Systemic Lupus Erythematosus. Reply. Obinutuzumab治疗活动性系统性红斑狼疮。回复。
IF 84.5 1区 医学
New England Journal of Medicine Pub Date : 2026-10-15 DOI: 10.1056/NEJMc2610854
Richard A Furie, Edward M Vital, Oliver Meier
{"title":"Obinutuzumab in Active Systemic Lupus Erythematosus. Reply.","authors":"Richard A Furie, Edward M Vital, Oliver Meier","doi":"10.1056/NEJMc2610854","DOIUrl":"https://doi.org/10.1056/NEJMc2610854","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"395 15","pages":"1562"},"PeriodicalIF":84.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书